Global Alliance for tb Drug Development

Top Publications

Top Publications Authored or Co-Authored in "Global Alliance for tb Drug Development"

• Burden of childhood tuberculosis in 22 high-burden countries: A mathematical modelling study

  The Lancet Global Health, Volume 2, No. 8, Year 2014, Citations 300
• Phase II dose-ranging trial of the early bactericidal activity of PA-824

  Antimicrobial Agents and Chemotherapy, Volume 56, No. 6, Year 2012, Citations 123
• Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicentre, open-label, partially randomised, phase 2b trial

  The Lancet Respiratory Medicine, Volume 7, No. 12, Year 2019, Citations 93
• Randomized dose-ranging study of the 14-day early bactericidal activity of bedaquiline (TMC207) in patients with sputum microscopy smear-positive pulmonary tuberculosis

  Antimicrobial Agents and Chemotherapy, Volume 57, No. 5, Year 2013, Citations 75
• A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB

  International Journal of Tuberculosis and Lung Disease, Volume 25, No. 4, Year 2021, Citations 39